Effects of Calcium and Guanethidine on Noradrenaline Output Induced by Sodium Reduction in Rabbit Atria

Misu, Yoshimi; Hosotani, Teruko; Nakashima, Emi; Nishio, Hiroaki

doi:10.1254/jjp.27.745

Cited by 1 publication

(1 citation statement)

References 9 publications

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there is no direct evidence that the drug increases the permeability of adrenergic nerve endings to ionized sodium, if it were the case, guanethidine might prevent the effect on nerve terminals induced by reduction of the exter-nal sodium concentration. Preliminary findings revealed that in rabbit atria, guanethidine inhibits the output of noradrenaline induced by low sodium (Misu, Hosotani, Nakashima & Nishio, 1977). In the present experiments, we investigated in detail the mechanism responsible for this action of guanethidine and related adrenergic neurone blockers on the output of noradrenaline induced by sodium reduction in rabbit ventricular slices.…”

Section: Introductionmentioning

confidence: 79%

Prevention by Guanethidine Analogues of Output of Noradrenaline Induced by Sodium Reduction in Rabbit Ventricular Slices

Hosotani

Misu

1978

British J Pharmacology

View full text Add to dashboard Cite

The prevention by guanethidine and related agents of the output of noradrenaline induced by low sodium was investigated in rabbit ventricular slices. When external NaCl was reduced, the output of noradrenaline into the medium collected at 30 min intervals, increased and the endogenous levels decreased. These changes induced by replacing sodium with sucrose or choline were not affected either by the omission of calcium and addition of 0.5 mm ethylene glycol‐bis(aminoethyl‐ether)N,N,N′,N′ tetra‐acetic acid (EGTA) or by an increase in the calcium concentration to 10 mm 30 min before sodium deprivation. Guanethidine 4 × 10−6 and 4 × 10−5m and 4–7‐exo‐methylene‐hexahydroisoindoline‐ethyl guanidine (No. 865‐123) 4 × 10−5 to 8 × 10−4m inhibited, in a dose‐dependent manner, increases in output of noradrenaline induced by reduction of sodium to 18 mm, while guanethidine 8 × 10−5m and high doses of bretylium produced no inhibition: the latter two released noradrenaline. The inhibitory actions of guanethidine 4 × 10−5m and No. 865‐123 4 × 10−4m were prevented by tetracaine 3.3 × 10−4m, which per se did not modify the output of noradrenaline induced by 18 mm sodium. Accumulation of guanethidine and No. 865‐123 in ventricular slices was greater than that noted in striated muscle slices and was dose‐, time‐ and temperature‐dependent. Tetracaine 3.3 × 10−4m did not prevent the accumulation of guanethidine 4 × 10−5m and No. 865‐123 1.1 × 10−6 to 4 × 10−4m. The guanidine derivatives appear to increase the permeability of adrenergic nerve endings to sodium ions.

show abstract

Section: Introductionmentioning

confidence: 79%